Lehrstuhl für Haut- und Geschlechtskrankheiten

Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma (2020) Wessely A, Heppt M, Kammerbauer C, Steeb T, Kirchner T, Flaig MJ, French LE, et al. Journal article Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases (2020) Berking C, Schadendorf D, Weichenthal M, Eigentler T, Mohr P, Schober K, Kiecker F, et al. Conference contribution Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI). (2020) Rogiers A, Tondini C, Grimes JM, Trager MH, Nahm S, Zubiri L, Papneja N, et al. Conference contribution Network and Systems Biology Approaches in Glial Cells (2020) Vera González J, Cantone M, Blume C Book chapter / Article in edited volumes HSV-1 Modulates IL-6 Receptor Expression on Human Dendritic Cells (2020) Birzer A, Krawczyk A, Draßner C, Kuhnt C, Mühl-Zürbes P, Heilingloh C, Steinkasserer A, Popella L Journal article Treatment Decision when there is an Indication for adjuvant Therapy for Melanoma - multicenter Real World Data (2020) Lodde G, Forschner A, Wulfken LM, Meier F, Mohr P, Kaehler KC, Schilling B, et al. Conference contribution SERIO - Side Effect Registry Immuno-Oncology Side Effect Registry for rare, severe and complex Side Effects of Immunotherapy (2020) Kramer R, Mentzer D, Erdmann M, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel S, et al. Conference contribution Effectiveness of Dabrafenib plus Trametinib during the Treatment of Melanoma Patients with BRAFV600 mutated Brain Metastases (2020) Berking C, Schadendorf D, Weichenthal M, Eigentler T, Schober K, Mohr P, Kiecker F, et al. Conference contribution The Quality of Guidelines for the Treatment of Cutaneous Melanoma: A methodological Assessment (2020) Steeb T, Wessely A, Drexler K, Salzmann M, Toussaint F, Heinzerling L, Reinholz M, et al. Conference contribution Cryopreservation reduces the Ability to migrate and the Cytotoxicity of natural Killer Cells in 3D: Possible Effects on cellular Immunotherapy (2020) Mark C, Czerwinksi T, Roessner S, Mainka A, Hoersch F, Heublein L, Winterl A, et al. Conference contribution